GITR/GITRL:

Stavros P Papadakos1, Elena Chatzikalil1, Georgios Vakadaris2,3

  • 1First Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, 11527 Athens, Greece.

Cancers
|July 27, 2024
PubMed
概括

向葡萄糖皮质激素诱导的TNFR相关蛋白 (GITR) 和其配体 (GITRL) 显示出治疗肝细胞癌 (HCC) 的前景. 这种免疫治疗方法可以改善晚期肝癌患者的治疗反应.